Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities

References

• O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009;373:1891-904
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report-2012. J Heart Lung Transplant 2012;31:1073-86
   PubMed Web of Science ®Google Scholar
• Liou TG, Adler FR, Cahill BC, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001;286:2683-9
   PubMed Web of Science ®Google Scholar
• Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007;357:2143-52
   Web of Science ®Google Scholar
• Liou TG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005;171:1053-9
   PubMed Web of Science ®Google Scholar
• Garrity ER. Should adults with cystic fibrosis receive lung transplants? Am J Respir Crit Care Med 2013;187:1283-4
   Google Scholar
• Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226-32
   PubMed Web of Science ®Google Scholar
• Egan TM, Murray SM, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6:1212-27
   PubMed Web of Science ®Google Scholar
• Tsiatis A, Davidian M. Joint modeling of longitudinal and time to event data: an overview. Stat Sin 2004;14:809-34
   Web of Science ®Google Scholar
• Thabut G, Christie JD, Mal H, et al. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. Am J Respir Crit Care Med 2013;187:1335-40
   PubMed Web of Science ®Google Scholar
• Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the pulmonary scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-55
   PubMed Web of Science ®Google Scholar
• Liou TG, Adler FG, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001;153:345-52
   PubMed Web of Science ®Google Scholar
• Ledson MJ, Gallagher MJ, Jackson M, et al. Outcome of Burkholderia cepacia colonization in an adult cystic fibrosis centre. Thorax 2002;57:142-5
   PubMed Web of Science ®Google Scholar
• Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001;163:43-8
   PubMed Web of Science ®Google Scholar
• Aris RM, Routh JC, LiPuma JJ, et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001;164:2102-6
   PubMed Web of Science ®Google Scholar
• Boussaud V, Guillemain R, Grenet D, et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 2008;63:732-7
   PubMed Web of Science ®Google Scholar
• Alexander BD, Petzold EW, Reller LB, et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008;8:1025-30
   PubMed Web of Science ®Google Scholar
• Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008;178:363-71
   PubMed Web of Science ®Google Scholar
• De Soyza A, Meachery G, Hester KLM, et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant 2010;29:1395-404
   PubMed Web of Science ®Google Scholar
• Levine SM. A survey of clinical practice of lung transplantation in North America. Chest 2004;125:1224-38
   Google Scholar
• McMenamin JD, Zaccone TM, Coenye T, et al. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 2000;117(6):1661-5
   PubMed Web of Science ®Google Scholar
• Aris RM, Gilligan PH, Neuringer IP, et al. The effect of panresistant bacteria in cystic fibrosis patients on lung transplantation outcome. Am J Respir Crit Care Med 1997;155:1699-704
   PubMed Web of Science ®Google Scholar
• Dobbin C, Maley M, Harkness J, et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 2004;56:277-82
   PubMed Web of Science ®Google Scholar
• Hadjiliadis D, Steele MP, Chaparro C, et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 2007c;26:834-8
   PubMed Web of Science ®Google Scholar
• Mydin HH, Corris PA, Nicholson A, et al. Targeted antibiotic prophylaxis for lung transplantation in cystic fibrosis patients colonised with Pseudomonas aeruginosa using multiple combination bactericidal testing. J Transpl 2012; doi:10.11552012/135738
   Google Scholar
• Olivier KN, Weber DJ, Wallace RJ, et al. Nontuberculous Mycobacteria: I. Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-34
   PubMed Web of Science ®Google Scholar
• Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005;43:3467-70
   PubMedGoogle Scholar
• Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999;160:1611-16
   PubMed Web of Science ®Google Scholar
• Chernenko SM, Humar A, Hutcheon M. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant 2006;25:1447-55
   PubMed Web of Science ®Google Scholar
• Lobo LJ, Chang LC, Esther CR, et al.Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections. Clin Transplant 2013;27:523-9
   PubMed Web of Science ®Google Scholar
• Qvist T, Pressler T, Thomsen VO, et al. Nontuberculous Mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Transplant Proc 2013;45:342-5
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Ardito F, Fiscarelli E, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001;39:816-19
   PubMed Web of Science ®Google Scholar
• Taylor JL, Palmer SM. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant 2006;25:985-8
   PubMed Web of Science ®Google Scholar
• Helmi M, Love RB, Welter D, et al. Aspergillus infection in lung transplant recipients with cystic fibrosis. Chest 2003;123:800-8
   PubMed Web of Science ®Google Scholar
• Nunley DR, Ohori P, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998;114:1321-9
   PubMed Web of Science ®Google Scholar
• Luong ML, Chaparro C, Stephenson A, et al. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation 2014;97:351-7
   PubMed Web of Science ®Google Scholar
• Singh N, Suarez JF, Avery R, et al. Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis. J Infect 2013;67:72-8
   Google Scholar
• Hadjiliadis D, Sporn TA, Perfect JR, et al. Outcome of lung transplantation in patients with mycetomas. Chest 2002;121:128-34
   Google Scholar
• Madill J, Gutierrez C, Grossman J, et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Transplant 2001;20:288-96
   Google Scholar
• Kanasky WF, Anton SD, Rodrigue JR, et al. Impact of body weight on long-term survival after lung transplantation. Chest 2002;121:401-6
   PubMed Web of Science ®Google Scholar
• Lederer DJ, Wilt JS, D’Ovidio F, et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009;180:887-95
   PubMed Web of Science ®Google Scholar
• Allen JG, Arnaoutakis GJ, Weiss ES, et al. The impact of body mass index on survival after lung transplantation. J Heart Lung Transplant 2010;29:1026-33
   PubMed Web of Science ®Google Scholar
• Bendan C, Ridout DA, Edwards LB, et al. Body mass index and its effect on outcome in children after lung transplantation. J Heart Lung Transplant 2013;32:196-201
   Google Scholar
• Williams JE, Wells JCK, Benden C, et al. Body composition assessed by the 4-component model and association with lung function in 6-12-y-old children with cystic fibrosis. Am J Clin Nutr 2010;92:1332-43
   Google Scholar
• Schwebel C, Pin I, Barnoud D, et al. Prevalence and consequences of nutritional depletion in lung transplant candidates. Eur Respir J 2000;16:1050-5
   PubMed Web of Science ®Google Scholar
• Hollander FM, van Pierre DD, de Roos NM, et al. Effects of nutritional status and dietetic interventions on survival in cystic fibrosis patients before and after lung transplantation. J Cyst Fibros 2013; doi: 10.1016/j.jcf.2013.08.009
   Google Scholar
• Cystic Fibrosis Foundation Patient Registry. 2012 Annual Data Report. Bethesda, Maryland
   Google Scholar
• Belle-van Meerkerk G, van de Graaf EA, Kwakkel-van Erp JM, et al. Diabetes before and after lung transplantation in patients with cystic fibrosis and other lung diseases. Diabet Med 2012;29:e159-62
   Google Scholar
• Hofer M, Schmid C, Benden C, et al. Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation. J Cyst Fibros 2012;11:131-6
   PubMed Web of Science ®Google Scholar
• Valour F, Brault C, Abbas-Chorfa F, et al. Outcome of cystic fibrosis-related diabetes two years after lung transplantation. Respiration 2013;86:32-8
   Web of Science ®Google Scholar
• Moran A, Becker D, Casella SJ, et al. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis–related diabetes: a technical review. Diabetes Care 2010;33:2677-83
   PubMed Web of Science ®Google Scholar
• Lamireau T, Monnereau S, Martin S, et al. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 2004;41:920-5
   PubMed Web of Science ®Google Scholar
• Efrati O, Barak A, Modan-Moses D, et al. Liver cirrhosis and portal hypertension in cystic fibrosis. Eur J Gastroenterol Hepatol 2003;15:1073-8
   Google Scholar
• Nash EF, Vollinga C, Gutierrez CA, et al. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis. Clin Transplant 2012;26:34-41
   PubMed Web of Science ®Google Scholar
• Klima LD, Kowdley KV, Lewis SL, et al. Successful lung transplantation in spite of cystic fibrosis-associated liver disease: a case series. J Heart Lung Transpl 1997;16:934-8
   PubMedGoogle Scholar
• Mendizabal M, Reddy KR, Cassuto J, et al. Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data. Liver Transpl 2011;17:243-50
   Google Scholar
• Milkiewicz P, Skiba G, Kelly D, et al. Transplantation for cystic fibrosis: outcome following early liver transplantation. J Gatroenterol Hepatol 2002;17:208-13
   Google Scholar
• Desai CS, Gruessner A, Habib S, et al. Survival of cystic fibrosis patients undergoing liver and liver-lung transplantations. Transplant Proc 2013;45:290-2
   PubMed Web of Science ®Google Scholar
• Lafarge M, Mordant P, Thabut G, et al. Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France. J Heart Lung Transplant 2013;32:905-13
   PubMed Web of Science ®Google Scholar
• Hämmäinen P, Schersten H, Lemström K, et al. Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study. J Heart Lung Transplant 2011;30:103-7
   Google Scholar
• Anile M, Diso D, Russo E, et al. Extracorporeal membrane oxygenation as bridge to lung transplantation. Transplant Proc 2013;45:2621-3
   PubMed Web of Science ®Google Scholar
• Garcia J, Iacono A, Kon Z, et al. Ambulatory extracorporeal membrane oxygenation: a new approach for bridge-to-lung transplantation. J Thorac Cardiovasc Surg 2010;139:e137-9
   PubMed Web of Science ®Google Scholar
• Hayes D Jr, Kukreja J, Tobias JD, et al. Ambulatory venovenous extracorporeal respiratory support as a bridge for cystic fibrosis patients to emergent lung transplantation. J Cyst Fibros 2012;11:40-5
   PubMedGoogle Scholar
• Bermudez CA, Rocha RV, Zaldonis D, et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. Ann Thorac Surg 2011;92:1226-32
   Google Scholar
• Smyth A, Lewis S, Bertenshaw C, et al. Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 2008;63:532-5
   PubMed Web of Science ®Google Scholar
• Quon BS, Mayer-Hamblett N, Aitken ML, et al. Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med 2011;184:1147-52
   PubMed Web of Science ®Google Scholar
• Quon BS, Mayer-Hamblett N, Aitken ML, et al. Risk of post-lung transplant renal dysfunction in adult with cystic fibrosis. Chest 2012;142:185-91
   PubMed Web of Science ®Google Scholar
• O’Connell OJ, Harrison MJ, Murphy DM, et al. Peri-transplant renal issues in patients with cystic fibrosis. Chest 2013;143:271
   Google Scholar
• Rocha PN, Rocha AT, Palmer SM, et al. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant 2005;5:1469-76
   PubMed Web of Science ®Google Scholar
• Maisonneuve P, Marshall BC, Knapp EA, et al. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst 2013;105:122-9
   PubMedGoogle Scholar
• Meyer KC, Francois ML, Thomas HK, et al. Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros 2011;10:366-9
   PubMedGoogle Scholar
• Aris RM, Maia DM, Neuringer IP, et al. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient. Am J Respir Crit Care Med 1996;154:1712-17
   PubMed Web of Science ®Google Scholar
• Kremer BE, Reshef R, Misleh JG, et al. Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases. J Heart Lung Transplant 2012;31:296-304
   Google Scholar
• Reshef R, Vardhanabhuti S, Luskin MR, et al. Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder. Am J Transplant 2011;11:336-47
   PubMed Web of Science ®Google Scholar
• Eakin MN, Riekert KA. The impact of medication adherence on lung health outcomes in cystic fibrosis. Curr Opin Pulm Med 2013;19:687-91
   PubMed Web of Science ®Google Scholar
• Kugler C, Fuehner T, Dierich M, et al. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation. Transplantation 2009;88:129-34
   Google Scholar
• Oliva M, Singh TP, Gauvreau K, et al. Impact of medication non-adherence on survival after pediatric heart transplantation in the USA. J Heart Lung Transplant 2013;32:881-8
   PubMed Web of Science ®Google Scholar
• Hayes D Jr, Higgins RS, Kirkby S, et al. Impact of pulmonary hypertension on survival in patients cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry. J Cyst Fibros 2014; In press
   Google Scholar
• Venuta F, Tonelli AR, Anile M, et al. Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation. J Cardiovasc Surg 2012;53:817-20
   Google Scholar
• Tonelli AR, Fernandez-Bussy S, Lodhi S, et al. Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival. J Heart Lung Transplant 2010;29:865-72
   Google Scholar
• Blondeau K, Dupont LJ, Mertens V, et al. Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 2008;57:1049-55
   PubMed Web of Science ®Google Scholar
• Button BM, Roberts S, Kotsimbos TC, et al. Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J Heart Lung Transplant 2005;24:1522-9
   PubMed Web of Science ®Google Scholar
• Mendez BM, Davis CS, Weber C, et al. Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis. Am J Surg 2012;204:e21-6
   PubMed Web of Science ®Google Scholar
• Davis RD, Lau CL, Eubanks S, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125:533-42
   PubMed Web of Science ®Google Scholar
• Hayes D Jr, Kirkby S, McCoy K, et al. Reduction of lipid-laden macrophage index after laparoscopic Nissen fundoplication in cystic fibrosis patients after lung transplantation. Clin Transplant 2013;27:121-5
   Google Scholar
• Hoppo T, Jarido V, Pennarthur A, et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg 2011;146:1041-7
   PubMedGoogle Scholar
• Flume PA, Mogayzel PJ, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010;182:298-306
   PubMed Web of Science ®Google Scholar
• Shigemura N, Bhama J, Gries CJ, et al. Lung transplantation in patients with prior cardiothoracic surgical procedures. Am J Transplant 2012;12:1249-55
   PubMed Web of Science ®Google Scholar
• Griffith BP, Hardesty RL, Armitage JM, et al. Acute rejection of lung allografts with various immunosuppressive protocols. Ann Thorac Surg 1992;54:846-51
   Google Scholar
• Garrity ER Jr, Villanueva J, Bhorade SM, et al. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation 2001;71:773-7
   PubMed Web of Science ®Google Scholar
• Palmer SM, Miralles AP, Lawrence CM, et al. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest 1999;116:127-33
   PubMed Web of Science ®Google Scholar
• Charpentier B, Rostaing L, Berthoux F, et al. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 2003;75:844-51
   PubMed Web of Science ®Google Scholar
• Duvoux C, Pageaux GP, Vanlemmens C, et al. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients. Transplantation 2002;74:1103-9
   PubMed Web of Science ®Google Scholar
• Jaksch P, Wiedemann D, Augustin V, et al. Antithymocyte globulin induction therapy improves survival in lung transplantation for cystic fibrosis. Transpl Int 2013;26:34-41
   Google Scholar
• Lobo LJ, Aris RM, Schmitz J, Neuringer IP. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart Lung Transplant 2013;32:70-7
   PubMed Web of Science ®Google Scholar